• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EYE
Click for more information
1.82% 27.0¢

NOVA EYE MEDICAL LIMITED - News & Media

Market Cap $61.77M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Nova Eye Medical Limited is an Australia-based medical technology company. The Company’s... Nova Eye Medical Limited is an Australia-based medical technology company. The Company’s principal activities include the design, development, manufacture, marketing, sale, and distribution of surgical devices for the treatment of glaucoma, a cause of blindness. The Company is also engaged in the commercialization of its ophthalmic laser, 2RT. The Company’s segments include AlphaRET and Glaucoma surgical devices. The Company's AlphaRET segment has 2RT, which is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD). 2RT is a patented nano-pause laser device that rejuvenates retinal structures compromised by AMD. The Glaucoma Surgical Devices segment includes the design, manufacture, marketing and sale of the iTrack, iTrack Advance, and the Molteno3 glaucoma surgical device. The Company's manufacturing facilities are located in Fremont, California, and Dunedin, New Zealand.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Articles & Videos

Nova Eye Medical reports surge in US sales

Nova Eye Medical (ASX:EYE) has reported a 65 per cent surge in USA sales revenue, reaching US$5.1 million for the six months ending December 31, 2023.

08 Jan 2024 14:47 (AEDT)

Nova Eye Medical's (ASX:EYE) iTrack Advance device approved for sale in the US

Nova Eye Medical's (ASX:EYE) iTrack Advance device has been cleared for sale to surgeons in the US to treat glaucoma.

31 Mar 2023 12:59 (AEDT)

Nova Eye Medical (ASX:EYE) raises $8m to fund expansion in US, Europe and China

Nova Eye Medical (ASX:EYE) has raised $8 million through a two-tranche share placement to fund the expansion of its Glaucoma Surgical Devices in the US, Europe and China.

02 Mar 2023 14:50 (AEDT)



(20min delay)
Last
27.0¢ 		Change
-0.005(1.82%) 		Mkt cap ! $61.77M
Open High Low Value Volume
27.0¢ 27.0¢ 25.5¢ $108.5K 410.6K

Buyers (Bids)

No. Vol. Price($)
4 157298 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 471179 1
View Market Depth
Last trade - 15.46pm 03/05/2024 (20 minute delay) ?
Last
26.5¢ 		  Change
-0.005 ( 0.00 %)
Open High Low Volume
26.5¢ 27.0¢ 25.5¢ 333518
Last updated 15.45pm 03/05/2024 ?
EYE (ASX) Chart

Top Stories

Car EV-olution accelerates Oz into pole position

As the world steers towards a more sustainable future, the surge in electric vehicle (EV) sales is turning industries upside down, and mining is no exception. Australia, famous for its treasure trove of minerals, finds itself right in the middle of this shift, which raises two questions. Firstly,...
Patagonia shares rise above 20% on lithium grades at maiden well in Argentina Patagonia Lithium shares rise above 12 percent on lithium grading nearly 600 parts per million at the first drill well of its Argentinian Formentera Lithium Project.
Macquarie profits fall 32% on 'market volatility' and low-achieving 'green investments' Macquarie Group Ltd (ASX:MQG) has shaved more than 30 percent off its net profit in the final quarter of the 2024 financial year (FY 2024), compared to the same time last year, with executives speaking cautiously about market volatility and @lower asset realisations’ from green in...
Dancing to that same 70s tune, China, and why I'm backing gold It is too early to judge what concrete measures the Future Made in Australia policy will entail. However, any policy which has a stated aim to screen qualifying capital for suitability at a government level, does not seem like a strong signal for foreigners to get on a plane, come visit some mine sites and invest.
Lithium Universe ends the quarter charged up for Quebec Refinery roll-out Lithium Universe has closed off the March quarter with a new Chief Financial Officer and strategically located land anchored for its lithium refinery in Quebec, Canada.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.